Needham Investment Management LLC Acquires 12,500 Shares of BWX Technologies, Inc. $BWXT

Needham Investment Management LLC increased its holdings in BWX Technologies, Inc. (NYSE:BWXT) by 53.2% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 36,000 shares of the technology company’s stock after purchasing an additional 12,500 shares during the period. Needham Investment Management LLC’s holdings in BWX Technologies were worth $6,222,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in BWXT. Aventura Private Wealth LLC bought a new stake in BWX Technologies in the 4th quarter worth approximately $29,000. Strategic Advocates LLC bought a new position in shares of BWX Technologies during the 3rd quarter valued at $32,000. Strategic Investment Solutions Inc. IL increased its position in BWX Technologies by 300.0% during the third quarter. Strategic Investment Solutions Inc. IL now owns 200 shares of the technology company’s stock valued at $37,000 after acquiring an additional 150 shares during the last quarter. WFA of San Diego LLC purchased a new stake in BWX Technologies during the second quarter valued at $29,000. Finally, Tucker Asset Management LLC bought a new position in BWX Technologies in the fourth quarter valued at about $36,000. Institutional investors own 94.39% of the company’s stock.

BWX Technologies Stock Up 0.5%

NYSE:BWXT opened at $194.32 on Tuesday. BWX Technologies, Inc. has a 1-year low of $133.84 and a 1-year high of $241.82. The company has a 50-day moving average of $209.09 and a 200 day moving average of $200.35. The firm has a market cap of $17.80 billion, a PE ratio of 51.96, a price-to-earnings-growth ratio of 3.19 and a beta of 0.73. The company has a debt-to-equity ratio of 1.58, a current ratio of 2.40 and a quick ratio of 2.33.

BWX Technologies (NYSE:BWXT) last announced its quarterly earnings results on Monday, May 4th. The technology company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $0.92 by $0.20. The firm had revenue of $860.22 million during the quarter, compared to analysts’ expectations of $837.47 million. BWX Technologies had a net margin of 10.20% and a return on equity of 31.33%. The company’s revenue was up 26.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.91 EPS. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. As a group, research analysts anticipate that BWX Technologies, Inc. will post 4.71 EPS for the current fiscal year.

BWX Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 5th. Stockholders of record on Tuesday, May 19th were given a dividend of $0.27 per share. The ex-dividend date of this dividend was Tuesday, May 19th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.6%. BWX Technologies’s dividend payout ratio is presently 28.88%.

Insiders Place Their Bets

In other news, CFO Michael Thomas Fitzgerald sold 2,417 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $209.25, for a total transaction of $505,757.25. Following the completion of the sale, the chief financial officer owned 6,884 shares in the company, valued at approximately $1,440,477. This represents a 25.99% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Rex D. Geveden sold 10,000 shares of the business’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $204.81, for a total value of $2,048,100.00. Following the transaction, the chief executive officer owned 202,491 shares in the company, valued at approximately $41,472,181.71. This trade represents a 4.71% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the company. Zacks Research downgraded BWX Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th. Bank of America increased their price objective on shares of BWX Technologies from $230.00 to $250.00 and gave the company a “buy” rating in a research report on Wednesday, March 25th. TD Securities assumed coverage on shares of BWX Technologies in a research report on Thursday, March 12th. They set a “buy” rating and a $230.00 target price on the stock. Wall Street Zen raised BWX Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of BWX Technologies from a “hold” rating to a “buy” rating and raised their target price for the stock from $205.00 to $255.00 in a report on Friday, May 15th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $228.00.

BWX Technologies Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.